PPP2R3A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.716400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.726000E-01
Normal-vs-Stage2
3.032000E-01
Normal-vs-Stage3
3.435200E-01
Normal-vs-Stage4
8.004200E-01
Stage1-vs-Stage2
6.468600E-01
Stage1-vs-Stage3
3.300200E-01
Stage1-vs-Stage4
8.770800E-01
Stage2-vs-Stage3
4.158200E-01
Stage2-vs-Stage4
5.496000E-01
Stage3-vs-Stage4
3.150000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.416400E-01
Normal-vs-AfricanAmerican
8.369600E-01
Normal-vs-Asian
3.915400E-01
Caucasian-vs-AfricanAmerican
2.475400E-01
Caucasian-vs-Asian
9.319000E-01
AfricanAmerican-vs-Asian
3.656000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.172000E-01
Normal-vs-Female
6.232800E-01
Male-vs-Female
8.670800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.348000E-01
Normal-vs-Age(41-60Yrs)
4.800800E-01
Normal-vs-Age(61-80Yrs)
2.212600E-01
Normal-vs-Age(81-100Yrs)
3.372800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.200600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.182400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.617800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.020000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.802200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.242600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.340400E-01
Normal-vs-Daily Drinker
4.375200E-01
Normal-vs-Weekly Drinker
6.274600E-01
Normal-vs-Occasional Drinker
3.816800E-01
Normal-vs-Social Drinker
8.385400E-01
Non Drinker-vs-Daily Drinker
2.473400E-01
Non Drinker-vs-Weekly Drinker
4.517000E-01
Non Drinker-vs-Occasional Drinker
6.193000E-01
Non Drinker-vs-Social Drinker
1.523610E-01
Daily Drinker-vs-Weekly Drinker
6.139900E-02
Daily Drinker-vs-Occasional Drinker
2.092800E-01
Daily Drinker-vs-Social Drinker
5.064100E-02
Weekly Drinker-vs-Occasional Drinker
8.815200E-01
Weekly Drinker-vs-Social Drinker
3.349000E-01
Occasional Drinker-vs-Social Drinker
3.009000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.616400E-01
Normal-vs-Grade 2
1.160390E-01
Normal-vs-Grade 3
1.770390E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.627870E-02
Grade 1-vs-Grade 3
1.081630E-02
Grade 1-vs-Grade 4
4.616400E-01
Grade 2-vs-Grade 3
2.356200E-01
Grade 2-vs-Grade 4
1.160390E-01
Grade 3-vs-Grade 4
1.770390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.425400E-01
Normal-vs-NonDiabetic
6.010200E-01
Diabetic-vs-NonDiabetic
9.997800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.454000E-01
Normal-vs-NoPancreatitis
2.529400E-01
Pancreatitis-vs-NoPancreatitis
4.426200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.982800E-01
Normal-vs-N1
6.429800E-01
N0-vs-N1
3.801800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.469400E-01
Normal-vs-TP53-NonMutant
3.496800E-01
TP53-Mutant-vs-TP53-NonMutant
3.176600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
